NEW DELHI: India is likely to see the Oxford-AstraZeneca vaccine approved for emergency use in the coming days, as updated data presented by the Serum Institute of India (SII) appears “satisfactory,” top government sources said. Once the data assessment is complete, the regulator may not wait for the vaccine to …
Read More »
The Covishield coronavirus vaccine was developed by AstraZeneca and the University of Oxford (file) New Delhi: The Oxford coronavirus vaccine “will protect 95 percent of patients” and is “as effective as the Pfizer and Moderna alternatives,” AstraZeneca CEO Pascal Soriot told Britain’s The Sunday Times, adding that the Scientists had …
Read More »
The drug regulator may give the Oxford COVID-19 vaccine a go-ahead next week. (Figurative) New Delhi: With preparations underway for a potential vaccine launch in January, India’s drug regulator is looking into the UK, which sources say may give the Oxford COVID-19 vaccine its go-ahead next week, ahead of decide …
Read More »
Vaccine manufacturers must have protection against all lawsuits for their vaccines, especially during a pandemic, said Serum Institute of India (SII) executive director Adar Poonawalla. He also said that vaccine manufacturers are going to propose this to the government, while speaking on a virtual panel about the challenges of developing …
Read More »
The institute had opened its doors for seniors on December 7 according to an order from the state government. Seventy-one residents of the Indian Institute of Technology Madras (IIT-M) tested positive for coronavirus. This includes 66 students. After this, the institute closed its laboratories, library and departments. The institute opened …
Read More »
India will deploy its vast electoral machinery to administer 600 million doses of COVID-19 vaccinates the most vulnerable people in the next six to eight months through conventional cold chain systems, the expert leading the initiative said on Friday. The government has lined up cold storage facilities with temperatures between …
Read More »
NEW DELHI: India, the world’s largest vaccine maker, is expected to launch its first vaccines in the coming weeks with at least three candidates under active consideration by India’s drug regulator. The Pune-based Serum Institute of India and Hyderabad-based pharmaceutical company Bharat Biotech have already approached the Controller General of …
Read More »
Marking the formal beginning of the evaluation process for Covid-19 vaccine candidates who have applied for emergency clearance in India, the Central Organization for Standard Medicines decided to seek additional safety and efficacy data from the Serum Institute of India and Bharat Biotech before giving the approval. Pfizer’s request was …
Read More »
Written by Kaunain Sheriff M | New Delhi | Updated: December 9, 2020 10:03:07 am At the Serum Institute of India on Monday. (Photo: Reuters) One crore of health workers, two crore of frontline workers, including the police and armed forces, and around 27 crore of people over 50 and …
Read More »
NEW DELHI: A committee of experts from the Central Drug Standard Control Organization (CDSCO) on Wednesday sought additional safety and efficacy data for Covid-19 vaccine candidates from Serum Institute and Bharat Biotech, after deliberating on their applications to obtain an emergency use authorization for injections. official sources said. The request …
Read More »